Kazia Therapeutics KZIA
NASDAQ KZIA
$9.27 -0.20 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Gross Profit (2009)

Updated

Kazia Therapeutics' Gross Profit was $2.17 million in the year ended Jun 30, 2011, up 21.8% from $1.78 million a year earlier.

Analysis

Kazia Therapeutics (KZIA) Gross Profit (2009) Analysis & Trends

  • Per Business Quant data, Gross Profit in earlier years was $1.78 million in the year ended Jun 30, 2010 and $6.84 million in the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Kazia Therapeutics 69.81 Mn 69.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 -501,000.00
API Access

Kazia Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KZIA&period=max&api_key=YOUR_API_KEY